GlassScriptPhysician profile
Shaheryar Ansari
NPI 1659646917
$15,617.50
in general payments reported to CMS, 2019-2025
9 companies · $619 in 2025
The $619 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $474 · 2020: $629 · 2021: $1,991 · 2022: $3,255 · 2023: $1,365 · 2024: $7,284 · 2025: $619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Food and Beverage: $1,672 · Consulting Fee: $1,160 · Travel and Lodging: $417 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Food and Beverage | $1,671.53 |
| Consulting Fee | $1,160.00 |
| Travel and Lodging | $416.74 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arteriocyte Medical Systems, INC. | $6,579.75 | 2024-2025 | Magellan |
| Medtronic, INC. | $4,186.41 | 2021-2025 | Anteralign Spinal System With Titan Nanolock Surface Technology, Mazor X System, Strata |
| Stryker Corporation | $3,634.04 | 2019-2025 | Optablate, Spinejack, Core |
| Medtronic USA, INC. | $1,002.52 | 2019-2020 | |
| Depuy Synthes Sales INC. | $94.20 | 2025 | Na, Matrixneuro, Synthecel |
| Abbvie INC. | $68.24 | 2023-2024 | Botox |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Biocomposites INC | $17.72 | 2024 | |
| Mallinckrodt Enterprises LLC | $14.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaheryar Ansari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.